|
|
 |
|
Viewing report
|
|
 |
 |
Neoforma Inc - Financial Report
Life Science Analytics, March 2008, Pages: 11
The Neoforma Inc Financial Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues. The report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally the report includes quarterly book value per share vs. share price. Much of the information contained in the report is included in both tabular and graphic formats.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The Neoforma Inc Financial Report therefore delivers the latest and the most comprehensive intelligence available on Neoforma Incs financial performance.
Customers who bought this item also bought
Global Biopharma Outlook 2011
Human Vaccines - Global Strategic Business Report
Breast Cancer Therapeutics - Global Strategic Business Report
Feminine Hygiene Products - Global Strategic Business Report
Mail Order and Internet Pharmacy in Europe: Embracing the New Challenge
Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report
Pain Management - Global Strategic Business Report
Nuclear Medicine - Global Strategic Business Report
Global Biopharma Outlook 2011: India Pharma
Food Allergy and Intolerance Products - Global Strategic Business Report
|
 |
|
|